Literature DB >> 1875216

The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma.

C G Price1, J Meerabux, S Murtagh, F E Cotter, A Z Rohatiner, B D Young, T A Lister.   

Abstract

Peripheral blood mononuclear cell fractions from 15 patients in continuous clinical remission from follicular lymphoma for longer than 10 years were examined for cells carrying the t(14;18) translocation using the polymerase chain reaction (PCR). The assay used was able to detect one positive cell in approximately 5 x 10(5) cells (a single 14q+ molecule in 2.5 micrograms DNA). Cells positive for t(14;18) were found in six of eight patients initially presenting with stage III or IV disease, compared with zero of seven of those with stage I or II disease (P less than .05). In two cases 14q+ junction regions were also successfully amplified from formalin-fixed biopsy material obtained at presentation 12 and 17 years previously. In both, sequence analysis demonstrated that the cells circulating in remission belonged to the original clone. These results indicate that cells bearing t(14;18) frequently persist in the peripheral blood in long remission of advanced follicular lymphoma and question the value of their presence as a predictor of relapse.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875216     DOI: 10.1200/JCO.1991.9.9.1527

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  8 in total

1.  Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

Authors:  Andrew J Davies; Andreas Rosenwald; George Wright; Abigail Lee; Kim W Last; Dennis D Weisenburger; Wing C Chan; Jan Delabie; Rita M Braziel; Elias Campo; Randy D Gascoyne; Elaine S Jaffe; Konrad Muller-Hermelink; German Ott; Maria Calaminici; Andrew J Norton; Lindsey K Goff; Jude Fitzgibbon; Louis M Staudt; T Andrew Lister
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

Review 2.  Low-grade lymphomas: new entities and treatment concepts.

Authors:  F B Hagemeister
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

Review 3.  High-throughput sequencing for noninvasive disease detection in hematologic malignancies.

Authors:  Florian Scherer; David M Kurtz; Maximilian Diehn; Ash A Alizadeh
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

4.  Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma.

Authors:  F Bertoni; G Bosshard; E Roggero; E Ceresa; F Cavalli; E Zucca
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.

Authors:  Giulia Motta; Michele Cea; Eva Moran; Federico Carbone; Valeria Augusti; Franco Patrone; Alessio Nencioni
Journal:  Clin Dev Immunol       Date:  2011-03-06

6.  Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis.

Authors:  R Yuan; P Dowling; E Zucca; H Diggelmann; F Cavalli
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

Review 7.  The molecular detection of circulating tumour cells.

Authors:  P W Johnson; S A Burchill; P J Selby
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

8.  Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification.

Authors:  T F Hickish; H Purvies; J Mansi; M Soukop; D Cunningham
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.